Uncoupling protein-2 (UCP2) was discovered in 1997 but a definitive understanding of its functions has so far eluded investigators. Potential roles include regulating fat metabolism directly and indirectly via effects on insulin secretion. Also, UCP2 could also negatively modulate the production of reactive oxygen species (ROS). Although evidence in support of these functions is correlational, research on UCP2 mechanisms of action has recently been published. Studies of polymorphisms in the uncoupling protein-2 gene have not been included in detail here but are reviewed elsewhere [1, 2] . For an in depth discussion of the uncoupling protein family of proteins, readers are referred to recent reviews [1, 3].
the enzyme complexes (I±IV) of the electron transport chain to pump H + out of the mitochondrial matrix ( Fig. 1 ). This creates a large electrochemical gradient of about ±170 mV, known as the proton-motive force. In a tightly coupled system, protons can only re-enter the mitochondrial matrix via ATP synthase with the potential energy derived from the protonmotive force captured as the high energy phosphate bond (~P) in ATP. The terminal step in the electron transport chain is the reaction 2H + + 2e ± + 1/2 O 2 ®H 2 O, thereby keeping the intracellular proton concentration low. In an uncoupled state, proton reentry bypasses ATP synthase, reducing the protonmotive force without capturing the potential energy, which is released as heat [4] .
Nature has provided proteins that act as uncouplers of oxidative phosphorylation. The most studied is uncoupling protein-1 (UCP1, thermogenin), found in abundance in the brown adipose tissue (BAT) of rodents, neonates of other mammalian species [4] , and in small quantities in white adipose tissue (WAT) . Here it appears to be expressed in multilocular cells similar to brown adipocytes [5] . Uncoupling protein-1 is part of a superfamily of proteins that includes mitochondrial carriers for ADP and ATP, and oxoglutarate and malate among others, plus related proteins in invertebrates, plants and fungi [4, 6, 7] . It might be surmised that cells expressing UCPs can metabolize fuels without production of~P, resulting instead in the production of heat. This process might therefore regulate metabolic efficiency and provide a mechanism for non-shivering thermogenesis. However, the near absence of UCP1 in adult mammals, including humans, has led to the hypothesis that equivalent molecules must exist to perform thermogenic and other regulatory functions.
Discovery of UCP2
In 1997 two groups using cloning approaches nearly simultaneously reported the existence of a protein having high homology to UCP1 that was named UCP2 [8, 9] . Uncoupling protein-2 transfected into yeast slows its growth and dissipates its mitochondrial membrane potential [8, 9] . The UCP2 gene is found on human chromosome 11 (mouse chromosome 7) in a region linked to obesity [8] . Coincidentally, a third laboratory investigating the phenotype of UCP1 null mutant (±/±) mice failed to observe development of obesity, as might be expected if UCP1 was solely responsible for diet-induced thermogenesis. Instead, they identified the induction of UCP2 as a possible explanation [10] . Subsequently, two other mammalian homologues were added to the family and termed UCP3 [11, 12] and UCP4 [13] . Uncoupling protein-4 and a fifth protein, brain mitochondrial carrier protein-1 [14] have low homology with UCPs 1±3 [1] .
Localization and chemical similarities of UCP2 to other proteins
Northern blot or PCR-based analyses show fairly ubiquitous expression of UCP2 mRNA but are in abundance in WAT, immune-associated tissues such as spleen and macrophages [8] and pancreatic islets [15, 16] . Uncoupling protein-2 mRNA is also expressed in skeletal muscle, although at lower amounts than UCP3 mRNA [17] . The distribution of UCP2 mRNA in areas of the brain associated with metabolic and thermal regulation in both rodents [18] and nonhuman primates [19] is also intriguing. Quantitative studies of protein expression are hampered by the lack of a suitable antibody for immunoblotting [3, 20] . However, immunocytochemical analysis shows that the UCP2 protein is present in pancreatic + re-enters the mitochondrial matrix through ATP synthase to generate ATP from ADP and P i . In less tightly coupled states, H + can transit the membrane via uncoupling proteins (UCP), thereby resulting in oxidation of glucose without concomitant production of ATP. Mechanism of ROS formation in cells: when the proton-motive force is large, the half-life of superoxide-generating electron transport intermediates such as ubisemiquinone is prolonged. CoQ, coenzyme Q (ubiquinone); cyt C, cytochrome C endocrine but not in exocrine tissues [15] . A recent description of an UCP2 antibody suitable for western blotting [21] should lead to a better understanding of the protein's regulation. For example, that study [21] suggests that while the UCP2 mRNA is detected in both WAT and skeletal muscle, the protein is only detectable in WAT.
Uncoupling protein-2 shares about 56 % [9] and UCP3 about 57 % amino acid identity with UCP1. Uncoupling protein-2 is highly conserved among species, having 95 % homology between human and murine entities [9] 
Functions of UCP1
The known functions of UCP1 provide a starting place for research into the physiological importance of the novel UCPs. The observation that UCP1 ±/± mice cannot maintain body temperature when coldchallenged [10] proves the primary role of UCP1 in cold-activated nonshivering thermoregulation of rodents. When mice are acutely exposed to cold, activation of b3-adrenergic receptors increases lipolysis within the BAT. The increase in NEFAs activates proton transport by UCP1 [35] . Long term cold stress increases circulating thyroid hormone concentrations and potentiates the sympathetic response [36] . Triiodothyronine treatment of brown adipocytes increases UCP1 protein expression, probably by stabilizing the mRNA transcript [36, 37] However, in the studies with UCP1 ±/± mice, excessive weight gain is not observed [10] leading to the conclusion that other factors regulating diet-induced thermogenesis exist. The initial observations that UCP2 is strongly induced in BAT [42] and WAT [16] in response to leptin treatment led to a flurry of experiments to determine the implications. The discovery of UCP2 in WAT and to a lesser extent in skeletal muscle, both tissues being potentially important for diet-induced thermogenesis [43] , was a further impetus to pursue this line of questioning. and not correlated with an increase in nonphosphorylating mitochondrial metabolism in mice [50] . Uncoupling protein-2 is upregulated by fasting in rodent skeletal muscle [45, 54] , which is not consistent with it having a role in diet-induced thermogenesis. Likewise, hypocaloric diets increase UCP2 mRNA expression in both WAT and skeletal muscle of human subjects [17] . Because the evidence is weak that UCP2 contributes substantially to adaptive thermogenesis under physiological conditions, this review emphasizes possible metabolic and immune defence functions.
Postulated functions of UCP2

Fuel metabolism
The potential sites at which UCP2 could regulate fuel metabolism include adipose tissue, skeletal muscle, endocrine pancreas and brain (Fig. 2) .
Adipose tissue. In BAT and WAT the properties of UCP2 appear to be suited to the regulation of fuel metabolism. For example, BAT UCP2 could regulate the use of lipids as fuel substrate for UCP1-mediated thermogenesis [54] . In rats, UCP2 expression in BAT is decreased after 48 h of starvation and restored to normal within 72 h of refeeding [54] . Refed rats have accelerated fat deposition without an increase in food intake, suggesting that UCP2 could enhance lipogenesis in the aftermath of starvation as a means of replenishing depleted fat stores [54] . However, a role for UCP2 in adaptive thermogenesis in BAT has not been completely ruled out [55] .
Studies in WAT are more applicable to human physiology and more strongly suggest an association of UCP2 with situations where fat metabolism is altered. In adipocytes, uncoupling of oxidative metabolism depresses lipogenesis [56] . Rodent studies show that UCP2 mRNA induction occurs with excessive fat intake [57, 58] . The increase is not dependent simply on caloric intake, because there is no effect on UCP2 expression of highly palatable diets with modestly ( < 20 %) increased fat content [59] . The ability of some individuals to resist weight gain might be related to their ability to upregulate UCP2, since mice resistant to weight gain on a high fat diet (A/J) induce UCP2 in WAT whereas obesity-prone mice (C57BL/6 J) do not [8, 60, 61] . Mice congenic for a segment of chromosome 7 containing polymorphisms in the UCP2 locus are susceptible to weight gain on a high fat diet. However, the congenic segment also contains the genes for TUB and UCP3, thereby limiting interpretation [62] . Thus, an impaired or delayed enhancement of UCP2 gene expression in adipose tissue in response to increased lipid intake could contribute to the onset of obesity in rodents.
In humans, the putative contribution of altered UCP2 gene expression in WAT to the pathogenesis of obesity is of great interest but unresolved. The quantity of UCP2 mRNA in subcutaneous abdominal fat is positively correlated with BMI [17] , which is consistent with the increased gene expression observed in WAT of ob/ob and db/db mice [9, 47]. However, others find no difference in UCP2 expression in subcutaneous abdominal fat in obese compared with lean subjects [63] . Moreover, in omental fat UCP2 mRNA is lower in the obese patients and remains lower after weight reducing surgery. One difference between the two studies is the effect of the weight loss intervention on plasma NEFA concentrations. In the first, plasma NEFA increases by 30 % in obese and 90 % in lean subjects [17] . In the second, no difference is seen before and 10 months after weight loss surgery [63] . A more recent study supports the idea that UCP2 expression in subcutaneous adipose tissue is negatively correlated with BMI but no short term regulation by NEFA is observed [64] . Lastly, UCP2 in healthy male subjects is described as variable, with no relation to resting metabolic rate [65] .
Attempts to demonstrate that NEFA can directly influence UCP2 expression in vivo also result in conflicting conclusions. Severe hyperlipidaemia (tenfold increase in plasma NEFA) created by prolonged infusion of triglyceride emulsions increases UCP2 gene expression in WAT by 120 % in normal weight subjects [66] but a moderate threefold increase in plasma NEFA has no effect [67] . Conjugated linoleic acid given in the diet of mice causes marked loss of weight and fat mass coordinate with a sixfold induction of UCP2 in WAT [68] . The magnitude of the conjugated linoleic acid effect far exceeds that of the triglyceride emulsions. The n-3 polyunsaturated fatty acids found in fish oils also induce UCP2 expression in WAT, and are associated with lower fat pad weight and lower leptin concentrations in KK ay mice [69] . With in vivo studies it is difficult to assess whether interventions affect UCP2 directly or indirectly. Diet or starvation alter hormone concentrations might also regulate UCP2. Of particular interest are insulin and leptin, because both influence UCP1 [70, 71] . In addition, both fasting plasma leptin [72] and insulin concentrations [72, 73] are negatively correlated with WAT UCP2 mRNA expression, although this finding is not supported by other data [65] . In wellcontrolled studies in rats, where leptin effects can be separated from those of weight loss, both intracerebroventricular [42] and peripherally-administered leptin [74] increase UCP2 expression in WAT. This effect is likely to be mediated by the sympathetic nervous system because leptin added directly to human adipocyte explants does not alter UCP2 expression [75] . However, when circulating leptin concentrations are increased threefold by inhibiting the sympathetic nervous system over 18 h, no changes in WAT UCP2 mRNA are observed [76] . This null effect is similar to studies in which feeding increases leptin but not UCP2 in subcutaneous abdominal fat [72] . Leptin is not obligatory for UCP2 expression in fat, because ob/ob mice have increased UCP2 [9, 77] and exogenous leptin treatment to these mice does not further increase UCP2 expression [77] . Less is known about the effect of insulin on UCP2 mRNA in WAT. Uncoupling protein-2 expression is not acutely regulated by plasma insulin as shown by hyperinsulinaemic clamp studies [17] or postprandial measurements [72] . In contrast, insulinopenic rats have increased UCP2 expression that is normalized by insulin therapy [78] . However, as insulin treatment also ameliorates the hyperlipidaemia associated with diabetes [78] , the effects of insulin could be indirect. As with the lipid infusion studies, it could be necessary to invoke an intense hormonal stimulus in order to see effects on UCP2 transcription. It will be important to learn more about the post-translational effects of putative regulators of UCP2 because of the potential of its more acute activation.
The mechanism by which UCP2 activity in WAT is putatively increased by NEFA exposure is not known. UCP1 is directly activated by NEFA posttranslationally [79] . However, so far the evidence is far stronger for transcriptional than post-translational induction of UCP2 activity by NEFA [33] . The peroxisome proliferator-activated receptors (PPARs) act as activators of transcription [80] . Peroxisome proliferator-activated receptor-g is activated by NEFA and induces genes associated with fat metabolism [81] . In adipose tissue, agonists of PPAR-g augment UCP2 expression in rodents and humans [75, 82±85] . Peroxisome proliferator response elements are associated with the promoter regions of the UCP2 [52] and the UCP3 genes [86] . Responsiveness of UCP2 transcription to PPARg is lost upon mutation of specific motifs in an enhancer region of the UCP2 gene but because PPARg does not bind to this region, its action is thought to be indirect [87] .
An alternative to the PPAR hypothesis of UCP2 transcriptional regulation is the potential for sympathetic nervous system-mediated upregulation. This hypothesis is viable because conditions such as fasting and cold exposure that activate lipolysis are associated with sympathetic activation. The 5'-flanking region of the UCP2 gene contains multiple cyclic AMP response elements [52, 88] . In clonal adipocytes, cyclic AMP-dependent protein kinase A activation induces UCP2 gene expression after 12 h exposure [88] . However, neither in vitro exposure to b2-or b3-sympathetic agonists [8, 88] or orally administered BRL 35 135 [73] induces UCP2 expression in WAT. In contrast, BRL 35 135 given intraperitoneally induces WAT UCP2 by two to threefold [89] . Inhibition of the sympathetic nervous system using toxins has no effect on epididymal adipose UCP2 [76] . Clearly, further work using in vivo models is required to understand UCP2 transcriptional regulation. In one of the first reports to emerge showing rigorous quantification of protein content, an increase in UCP2 protein without any change in mRNA is observed in stomach and lung after starvation but no results are reported for WAT [21] . These data do, however, raise the possibility of post-transcriptional regulation of UCP2 activity by the metabolic state.
Skeletal muscle. The pattern of changes in UCP2 gene expression in muscle tissue is consistent with a role in the regulation of lipid metabolism. Experiments in rats show a pronounced increase in muscle UCP2 mRNA in response to fasting [45, 54, 90] that is blunted by pretreatment with an antilipolytic agent [90, 91] . Also, when fasted rats are treated with an inhibitor of NEFA flux through beta-oxidation, increases are observed in both serum NEFA and soleus muscle (primarily oxidative) UCP2 mRNA [91] . However, UCP2 gene expression is attenuated in the tibialis anterior muscle, a tissue that shifts between lipid oxidation and glycolytic metabolism [91] . While fasting produces upregulation of UCP2 mRNA, refeeding on a low fat diet causes UCP2 mRNA in muscle tissue to plummet to below control values [92] . The fasting-induced increase in UCP2 gene expression is maintained in rats refed a high fat diet [92] . These ob-servations suggest the existence of a positive feedback loop between NEFA flux and UCP2 gene expression in skeletal muscle such that in oxidativetype muscle tissue UCP2 mRNA is regulated by serum NEFA concentrations while in oxidative-glycolytic-type muscle UCP2 gene expression is regulated by NEFA flux in mitochondria [91, 92] . However, more recently others have raised the possibility that insulin resistance rather than NEFA is more closely linked to UCP2 adaptations to fasting and refeeding [92, 93] .
In contrast, NEFA flux does not seem to be among the factors regulating UCP2 gene expression in glycolytic muscle fibres because anti-lipolytic agents are ineffective in blocking the fasting-induced increase in UCP2 mRNA in rat gastrocnemius muscle [55, 91] . High fat diet has no effect on UCP2 gene expression in the gastrocnemius muscle of both rats [57, 94] and mice [95] . However, more recently a modestly high fat diet (33 %) upregulated UCP2 gene expression by about 75 % in rat gastrocnemius muscle [59] . This increase is not correlated with weight gain, BAT mass, body temperature or plasma concentrations of leptin, insulin or triglycerides leading the authors to speculate that skeletal muscle UCP2 is significantly less labile than UCP2 found in BAT and WAT, thus requiring body fat stores to reach critical values before appreciable changes in local UCP2 gene expression are observed [59] . Alterations in UCP2 mRNA coincident with shifts in muscle metabolism in response to substrate availability support a proposed role for UCP2 in lipid metabolism.
In humans, there are conflicting data for muscle UCP2 gene expression correlations with BMI or the percentage of body fat [17, 96±99] . In contrast, patients with Type II (non-insulin-dependent) diabetes mellitus show increased UCP2 mRNA in the vastus lateralis muscle, a primarily oxidative-type tissue [97, 100] . While fasting in both lean and non-diabetic obese subjects results in an increased UCP2 gene expression [17, 100] no change is observed in diabetic patients [100] . To explain this phenomenon, the existence of an impaired lipolytic response by adipose tissue is proposed [100] . Given the apparent inducing effect of NEFAs on muscle UCP2 gene expression, the absence of a sufficient rise in serum NEFAs during calorie restriction in diabetic patients could preclude changes in muscle UCP2. However, contrary findings are also reported. When weight loss is induced by dietary restriction rather than fasting, UCP2 mRNA in vastus lateralis muscle increases slightly [96, 101] . Of interest, UCP2 expression in the vastus lateralis muscle of tetraplegic patients is increased by nearly fourfold compared with able-bodied subjects. Expression is normalized by treating the paralysed patients with an electrically-stimulated leg cycling program [102] . After endurance training in able-bodied athletes, the ability of NEFA to increase muscle oxygen consumption is increased, an effect correlated with the increase in UCP2 mRNA [103] . Because obese and Type II diabetic patients tend to have reduced physical activity, some of the changes observed in the studies cited above might be caused by inactivity.
Polyunsaturated NEFA such as w-6 fatty acids seem to influence UCP2 expression by multiple intracellular pathways. Using L6 myotubes, both cyclic AMP/protein kinase A-dependent and PPARb-dependent mechanisms of induction of gene transcription are detected. The cyclic AMP-dependent pathway is activated by cyclooxygenase-mediated processes [104] .
Pancreatic islets. The lipid content of pancreatic islet beta cells must be carefully regulated to optimize insulin secretion. Glucose-stimulated insulin secretion (GSIS) is abolished in normal islets depleted of triglyceride [105] while toxic lipid accumulation is a postulated mechanism in the beta-cell failure observed in the Zucker diabetic fatty (ZDF) rat [106, 107] . The observation that UCP2 gene expression is attenuated in the islets of ZDF rats [108] and is upregulated by high concentrations of leptin in normal islets [16, 106] or a PPAR-g ligand in ZDF islets [108] supports a role for UCP2 in the putative leptin-regulated pathway of intracellular fat homeostasis (Fig. 3) .
Overexpression of UCP2 mRNA in rat islets [15, 109] or clonal beta cells [109, 110] blunts GSIS and lowers cellular ATP, which is suggestive of the uncoupling properties of UCP2 [15] . Moreover, overexpression of UCP2 in beta cells leads to depolarization of the mitochondrial membrane potential [109] , a decrease in the ADP:O ratio, increased state 4 respiration [110] and reduced closure of ATP-dependent K + (K ATP ) channels [109] . Support for the hypothesis that UCP2 is a negative regulator of insulin secretion comes from investigations using UCP2 ±/± mice. These mice have increased circulating insulin concentrations concomitant with reduced blood glucose in the fed state. Insulin secretion from glucose-stimulated isolated islets is also significantly enhanced and the ATP:ADP ratio is increased [111] . Conversely, overexpression of UCP2 in ZDF rat islets shows an increase in preproinsulin mRNA together with an improvement in GSIS [112] . Additional investigation is warranted to further elucidate the contribution of UCP2 in islets to intracellular lipid metabolism and the stimulus-secretion coupling of insulin release.
Little is known about the regulation of UCP2 expression in beta cells. Both leptin [16] and PPAR-g ligands [108] are reported to induce UCP2 mRNA, implying that UCP2 could be regulated by NEFA [16] as described for other tissues. Indeed, chronic exposure of clonal beta cells to oleic acid impairs GSIS, lowers mitochondrial membrane potential and reduces the ATP:ADP ratio, correlating with increased UCP2 mRNA and protein [113] . Glucose metabolism is also implicated in the regulation of UCP2 transcription (Fig. 3) . The hepatic nuclear factor 4a (HNF4a) is a transcription factor expressed in islets, the absence of which leads to development of MODY1 [114] . When HNF4a is increased, GSIS is suppressed and ATP generation is attenuated. Because of pleiotropic effects on the expression of mitochondrial TCA cycle enzymes, substrate metabolism is greatly inhibited. However, in addition to these effects, HNF4a also elicits partial uncoupling of mitochondrial respiration that is accompanied by an increase in UCP2 mRNA expression [115] . Also, HNF1a, a second transcription factor acting downstream of HNF4a [115] , induces a similar phenotype including the increase in UCP2 and mitochondrial membrane depolarization [116] . Glucose could also directly alter UCP2 expression through negative regulation of PPARa [117] . It is well-documented that chronic exposure of islets to high glucose causes high basal insulin secretion but reduces the response to increased glucose [118] . Beta cells exposed to high glucose have reduced PPARa mRNA and protein within 6 h of exposure. A concomitant 75 % reduction of UCP2 mRNA is observed and basal insulin is increased [117] . The decrease in UCP2 is proposed to contribute to a decrease in NEFA oxidation, leading to increased cellular fatty acyl-CoA [117] . Together with increased glucose metabolism, such altered lipid partitioning is implicated in the development of glucolipotoxicity, which then leads to suppression of GSIS [119] .
Central nervous system. Specific regions of the brain, particularly the hypothalamus, are associated with the regulation of peripheral metabolism. In rodents, UCP2 mRNA is found in suprachiasmatic, arcuate and paraventricular nuclei of the hypothalamus and in the dorsomotor nucleus of the vagus nerve [18, 120] . In non-human primate hypothalamic centres, UCP2 is co-expressed in neurons producing neuropeptide Y (NPY), corticotrophin-releasing hormone (CRH), oxytocin and vasopressin [19] . The metabolic importance of neuronal pathways involving NPY and CRH is well-known; thus UCP2 could regulate the signalling of efferent pathways to affect peripheral weight regulation [19, 120] . In rats, cold exposure increases spinal cord, but not brain, UCP2 mRNA by about 50 % [121] . However, any changes in specific brain nuclei could be masked by the use of whole brain homogenates for northern blot analysis. The central nervous system remains an intriguing locus of UCP2 expression where its function remains entirely hypothetical.
Regulation of reactive oxygen species production
Normally, mitochondrial respiration results in the formation of reactive oxygen species (ROS), such as superoxide and hydrogen peroxide (H 2 O 2 ) (Fig. 1) . Experiments using isolated mitochondria show a positive correlation between the proton electrochemical gradient (Dm H+ ) and ROS production [122] because electron flow down the electron transport chain is in- hibited, thereby prolonging the half-life of intermediates capable of reducing O 2 to superoxide. Production of ROS is decreased by uncoupling agents that reduce Dm H+ [123] . Moderate concentrations of H 2 O 2 are beneficial, regulating the redox state of the cell and modulating transcription factors involved in cell proliferation and differentiation [124, 125] . Oxidative bursts generating ROS also provide a defence against infectious agents [136] . At toxic concentrations, ROS are capable of damaging cellular membranes, proteins and DNA leading to eventual mitochondrial destruction and cellular apoptosis [123, 127, 128] .
The hypothesis that UCP2 functions to limit ROS production is verified by studies in UCP2 ±/± mice infected with Toxoplasma gondii. Macrophages from these mice generate 80 % more ROS than control mice, brain lesion formation is markedly reduced and lethality of the infection absent [48] . Using clonal beta cells, others show that UCP2 overexpression reduces cell death induced by application of H 2 O 2 [129] . Increased uncoupling in vascular endothelial cells induced by UCP1 overexpression reduces ROS formation caused by hyperglycaemia [130] . Since UCP1 is not likely to be expressed naturally in endothelia, UCP2 could be a candidate for such function under physiological conditions.
Several correlational studies support a role of UCPs in suppressing ROS formation. In nonparenchymal liver cells, induction of UCP2 is associated with a decrease in H 2 O 2 production [131] . The ob/ob mouse has increased susceptibility to inflammatory hepatic lesions associated with a 200 % increase in ROS generation by hepatocyte mitochondria [132] . Models of fatty liver, including ob/ob mice, exhibit an increase in UCP2 mRNA, which is hypothesized to be an adaptive response to ROS [132, 133] . Of interest, PPAR-g mRNA is increased in ob/ob mouse hepatocytes and treatment with a PPAR-g ligand induces a further increase in UCP2 expression [134] . In contrast to liver, the UCP2 mRNA measured in macrophages of ob/ob mice is decreased and ROS production is increased relative to normal mice [135] . As with other tissues, this suggests tissue-specific regulation of UCP2 gene transcription.
Bacterial infection could involve systemic exposure to lipopolysaccharide (LPS), an endotoxin that induces fever and other elements of an immune response. Mice treated with LPS have increased UCP2 mRNA after 6 to 24 h [21, 136±138]. This correlates with an increase in core temperature but, because no increase in mitochondrial proton leak is detected [139] , the pyrogenic mechanism might not rely on UCP2. However, in another study an increase in liver UCP2 expression correlated with reduced O 2 consumption, null effect of dinitrophenol as an uncoupler, and reduced mitochondrial membrane potential [139] . Although TNF-a has been implicated in LPSmediated induction of UCP2 [137, 138] , knockout of the TNF-a gene in ob/ob mice results in a paradoxical increase in UCP2 gene expression [77] . Thus, the importance of cytokines such as TNF-a as regulators of UCP2 remains equivocal.
Altogether, these studies suggest that upregulation of UCP2 could be an adaptive response to inflammatory insult. While limited production of ROS might be helpful in eliminating invading organisms [48] , the ability to suppress ROS production under other circumstances is essential to prevent excessive tissue damage.
Relation of UCP2 with metabolic diseases
Many reports have shown that UCP2 expression in tissues varies according to the metabolic status of the subject. Originally, it was postulated that a primary change in UCP2 activity might lead to a disease state; the most popular hypothesis was that low UCP2 would lead to the development of obesity based on its putative role in diet-induced thermogenesis. Although a number of polymorphisms in UCP2 gene structure have been identified, only a few studies support a strong role for UCP2 mutations in the pathogenesis of obesity [2] .
In contrast with genetic linkage studies, many reports are consistent with the idea that UCP2 tissue expression adapts to changes in the metabolic state, in response to altered plasma NEFA concentrations or insulin sensitivity [91, 92] . It is therefore possible that chronic homeostatic disturbances could lead to maladaptive states, in which UCP2 might be an important participant.
The potential for UCP2 maladaptions to contribute to obesity has received considerable attention. Authors finding an inverse correlation between UCP2 and BMI in WAT suggest that the resultant increase in energy efficiency contributes to the pathogenesis and maintenance of an overweight state [72] . Although none of the UCP ±/± mice (1, 2 or 3) is obese [10, 48, 111, 140, 141] it remains to be determined how UCP2 interacts with other potential energy monitoring molecules to participate in weight homeostasis. Of interest are data showing that mice with skeletal muscle-specific induction of UCP3 have decreased body weight despite normal [142] or increased food intake [143] . The metabolic rate is increased, as is insulin sensitivity and glucose uptake, whereas adipose tissue mass is reduced by about 50 % [143] .
Unfortunately, genetically-defined rodent models of obesity do not provide a clear picture of what might apply to humans. In addition to the complications arising from the dominance of UCP1 in adaptive thermogenesis, there is considerable variability in reported tissue UCP2 mRNA. Since leptin appears to upregulate UCP2 [42, 74] , it might be hypothesized that leptin-deficient or leptin-resistant animals would have attenuated UCP2 expression. However, not only is leptin not essential for UCP2 expression, it seems that even similar causes of obesity have disparate effects on UCP2 expression [9, 16, 89, 144] . Moreover, expression of UCP2 in skeletal muscle of these rodents has rarely been reported. Although UCP3 is dominant in skeletal muscle, the large mass of the tissue increases the possibility that fluctuations of UCP2 content could have physiological relevance.
One explanation for the discrepancies could be the degree of diabetes coexisting with obesity in these animals. The fa/fa rat is insulin resistant but not diabetic, whereas ob/ob mice on a C57BL/6 J background exhibit mild diabetes [145] and the ZDF rat a more severe diabetes [146] . Type II diabetes mellitus is associated with hypertriglyceridaemia, hypercholesterolaemia and increased NEFA in plasma. As noted above, UCP2 expression in skeletal muscle of human diabetic patients is increased [97, 100] . In fa/fa rat muscle, no difference [144] or a decrease in expression is reported [89] . In contrast, non-obese rats made diabetic by streptozotocin injection initially have increased UCP2 in both WAT and skeletal muscle. After 3 weeks without insulin therapy, UCP2 mRNA in WAT remains increased whereas that in skeletal muscle returns to baseline [78] . Although there seems to be an adaptive response of UCP2 to diabetes, particularly in skeletal muscle, the relevance of this observation remains to be determined.
Obesity and diabetes are also associated with deranged insulin secretion and it has been hypothesized that UCP2 could play a part in the development of insulin insufficiency in diabetes. Rats fed a high fat diet for 3 weeks [109] and hyperlipidaemic, diabetic ob/ob mice [111] have increased islet UCP2 mRNA expression. Such lipid-associated upregulation could contribute to the development of insulin insufficiency and subsequent hyperglycaemia. Since hyperglycaemia also induces UCP2 expression [117] , it is possible that a feed-forward loop is generated which further exacerbates the insulin insufficiency, leading to the onset and progression of frank diabetes. Evidence for this hypothesis is provided by experiments showing that when ob/ob mice are crossed with UCP2 gene knockout mice, there is an improvement in glucose tolerance accompanied by increased insulin secretion [111] .
Relation of UCP2 to other pathological conditions
A deficiency of UCP2 was associated with protection from a parasitic infection [48] but what is not yet known is if the UCP2-deficient mice are more susceptible to age-related diseases, which could result from cumulative oxidative damage to tissues [147] . Future studies to examine a role for UCP2 as a protective factor against glucose-induced or lipid-induced ROS damage in diabetes and other chronic illnesses associated with ageing will clarify this potential role.
Conclusions
Since its discovery in 1997, at least 200 research papers have showed that despite the fairly ubiquitous distribution of UCP2 in tissues, its regulation and function could be tissue-specific. Evidence to support a role for UCP2 in adaptive thermogenesis is weak but there are substantive data suggesting that UCP2 could regulate energy homeostasis, particularly under conditions where NEFA are increased like in diabetes mellitus and fasting. The expression of UCP2 in pancreatic beta cells suggests both direct and indirect modulation of NEFA metabolism in skeletal muscle and WAT. In contrast, UCP2 could also limit ROS production, which can protect cells under some circumstances but could also leave animals susceptible to certain infectious processes. Of interest, NEFA exposure has also been associated with an increase in apoptosis in beta cells [148] ; therefore a link between the two postulated functions of UCP2 could be tissue lipid exposure. A recent paper assumes that UCP3 could function as an exporter of NEFA from the mitochondrial matrix when their supply is in excess [149] . Such export of anionic NEFA would have the same effect on mitochondrial membrane potential as the import of a proton. Thus, it will be of interest to discover whether UCP2 also acts as a NEFA transporter.
Sources. This review is based on the literature published in the English language since the discovery of UCP2 in 1997 and the earlier publications regarding UCP1 that are key to a background understanding. Sources for the period 1997 to 2001 are searched by PubMed for ªuncoupling proteinº, ªreactive oxygen speciesº, and ªinsulin secretion and lipotoxicity and glucotoxicityº. 
